SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8583135
Source:
http://linkedlifedata.com/resource/pubmed/id/8583135
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0035668
,
umls-concept:C0087111
,
umls-concept:C0220847
,
umls-concept:C0229671
,
umls-concept:C0279030
,
umls-concept:C0443252
,
umls-concept:C0444930
,
umls-concept:C0475208
,
umls-concept:C0681842
,
umls-concept:C1274040
pubmed:issue
5
pubmed:dateCreated
1996-3-19
pubmed:abstractText
Serum HCV RNA was quantitated by the competitive polymerase chain reaction before, at the end of, and after interferon therapy. We assessed whether serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatment.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8503886
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interferons
,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0168-8278
pubmed:author
pubmed-author:AiyamaTT
,
pubmed-author:IwataKK
,
pubmed-author:KakumuSS
,
pubmed-author:OkumuraAA
,
pubmed-author:TakayanagiMM
,
pubmed-author:YoshiokaKK
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
497-502
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:8583135-Adult
,
pubmed-meshheading:8583135-Base Sequence
,
pubmed-meshheading:8583135-Dose-Response Relationship, Drug
,
pubmed-meshheading:8583135-Drug Administration Schedule
,
pubmed-meshheading:8583135-Female
,
pubmed-meshheading:8583135-Follow-Up Studies
,
pubmed-meshheading:8583135-Genotype
,
pubmed-meshheading:8583135-Hepacivirus
,
pubmed-meshheading:8583135-Hepatitis C
,
pubmed-meshheading:8583135-Humans
,
pubmed-meshheading:8583135-Interferons
,
pubmed-meshheading:8583135-Male
,
pubmed-meshheading:8583135-Middle Aged
,
pubmed-meshheading:8583135-Molecular Sequence Data
,
pubmed-meshheading:8583135-Polymerase Chain Reaction
,
pubmed-meshheading:8583135-RNA, Viral
,
pubmed-meshheading:8583135-Retrospective Studies
,
pubmed-meshheading:8583135-Titrimetry
,
pubmed-meshheading:8583135-Treatment Outcome
pubmed:year
1995
pubmed:articleTitle
Serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatment.
pubmed:affiliation
Department of Internal Medicine, Nagoya University School of Medicine, Japan.
pubmed:publicationType
Journal Article